60
Participants
Start Date
December 1, 2021
Primary Completion Date
January 1, 2023
Study Completion Date
January 1, 2023
Galectin 3
Women diagnosed with Placenta Accreta Spectrum (PAS) were invited to join the study, providing they had no known systemic diseases (e.g. chronic hypertension, diabetes, hypothyroidism, chronic renal-liver diseases, etc.), autoimmune disorders, multiple pregnancies, or the presence of fetal structural and chromosomal anomalies. They also did not have cholestasis of pregnancy, preterm delivery, or evidence of chronic and active infection.
Necmettin Erbakan University Meram Medicine Faculty, Konya
Necmettin Erbakan University
OTHER